Gabriel Étienne

13.7k citations
110 papers · 6.2k indexed · 4 hit papers · h-index 28
Topics
Chronic Myeloid Leukemia Treatments (92 papers)Chronic Lymphocytic Leukemia Research (80 papers)Eosinophilic Disorders and Syndromes (38 papers)
Journals
New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Gabriel Étienne

101 papers receiving 6.1k citations

Hit Papers

Nilotinib versus Imatinib for Newly Diagnosed Chronic Mye...201020262015202020102010201620162505007501000

Peers

Gabriel Étienne
Comparison fields: 5 of 94
  • Hematology 5.3k
  • Genetics 4.3k
  • Rheumatology 2.5k
  • Oncology 1.0k
  • Molecular Biology 758
Replace Michael J. Mauro with:
Michael J. Mauro United States
Dragana Milojković United Kingdom
Gianantonio Rosti Italy
Susan O’Brien United States
Neil J. Gallagher United States
François‐Xavier Mahon France
Miloslav Beran United States
Miloslav Beran United States
Ellin Berman United States
Susan M. Geyer United States
Gabriel Étienne relative to Michael J. Mauro United States Michael J. Mauro's profile →
Citations per field
00.5×1.5×1.8×
Michael J. Mauro · 1×
Citations per year

Countries citing papers authored by Gabriel Étienne

Since Specialization
Citations

This map shows the geographic impact of Gabriel Étienne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Étienne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Étienne more than expected).

Fields of papers citing papers by Gabriel Étienne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Étienne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Étienne. The network helps show where Gabriel Étienne may publish in the future.

Co-authorship network of co-authors of Gabriel Étienne

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Étienne. A scholar is included among the top collaborators of Gabriel Étienne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Étienne. Gabriel Étienne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 8
5 0
6 37
7
Effect of dose modifications on response to duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the DUO trial
1
8 1
9 7
10 24
11
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trialbreakdown →
563
12 6
13 40
14 12
15
Nilotinib induces deeper molecular responses vs continued imatinib in patients with ph+ chronic myeloid leukemia (CML) with detectable disease after ≥ 2 years on imatinib: ENESTcmr 12-months results
0
16 75
17 10
18 174
19 33
20 468

About Gabriel Étienne

Gabriel Étienne is a scholar working on Hematology, Genetics and Rheumatology, having authored 110 papers that have together received 6.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (92 papers), Chronic Lymphocytic Leukemia Research (80 papers) and Eosinophilic Disorders and Syndromes (38 papers). The work is most often cited by research in Hematology (5.3k citations), Genetics (4.3k citations) and Rheumatology (2.5k citations). Gabriel Étienne has collaborated with scholars based in France, United States and Australia. Frequent co-authors include François‐Xavier Mahon, Delphine Réa, Josy Reiffers, Timothy P. Hughes, Andreas Hochhaus, Richard A. Larson, Laurence Legros, Giuseppe Saglio, Richard E. Clark and François Guilhot. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026